Personalized risk stratification for prostate cancer and the potential of whole-slide IR imaging

Pá, 30.10.2026 18:00 CET
Webinář ukáže, jak spektrální patologie a celoplošné IR zobrazování doplňují histopatologii a mohou podpořit objektivnější stratifikaci rizika karcinomu prostaty.
SelectScience: Personalized risk stratification for prostate cancer and the potential of whole-slide IR imaging
SelectScience: Personalized risk stratification for prostate cancer and the potential of whole-slide IR imaging

The molecular and spatial heterogeneity of prostate cancer complicates risk assessment and treatment planning. A key challenge is to map molecular tissue characteristics without losing the histopathological context, while meeting the throughput and reproducibility requirements of clinical research.

In this TechTalk, we will explore how label-free, stain-free whole-slide IR imaging can add a new dimension to tissue analysis. Using prostate cancer as a key application, we will show how spectral pathology combines chemical imaging with spatial information to characterize tissue and investigate its potential for more personalized risk stratification.

Certificate of attendance
  • If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. 
  • If you view the on-demand TechTalk, you can request a certificate of attendance by emailing [email protected].
Who should attend?
  • Pathologists and clinicians
  • Digital pathology specialists
  • Bioinformaticians working with tissue imaging
  • Researchers developing new diagnostic and personalized medicine approaches
What will this webinar cover?
  • How spectral pathology can complement conventional morphological tissue assessment
  • How spectral information could contribute to more objective risk stratification and support treatment decisions
  • How whole-slide IR imaging reveals label-free chemical information across tissue sections

Speaker: Dougal Ferguson, Ph.D. (Research Fellow, University of Manchester)

Dougal Ferguson is a Research Fellow currently researching artificial intelligence-driven infrared spectroscopic techniques for improved prostate cancer risk stratification at the University of Manchester. He has a PhD in Advanced Functional Materials and Analytical Science, and a Masters degree with Distinction in Statistics and Computational Finance from the University of York.

Bruker
LinkedIn Logo